Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Functional Dyspepsia
NCT04302402Phase 2Unknown
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Mar 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaximin in functional dyspepsia (FD), sponsored by Sanjay Gandhi Postgraduate Institute of Medical Sciences. Status: unknown.
02
Drugs
rifaximin
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT04302402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04302402.